Fibrinolysis in Intermediate-Risk PE Between Prevention and Risk – Unidad de ETV Hospital Gregorio Marañón
Unidad de ETV Hospital Gregorio Marañón shared a post on X about a recent article by Eva Cervilla-Muñoz et al., published in Journal of Clinical Medicine:
“The use of systemic fibrinolysis in intermediate-risk PE remains one of the great clinical debates: Prevent hemodynamic deterioration or assume greater hemorrhagic risk?
In our new article, conducted together with CardioHGUGM, we analyze a real-world cohort.”
Title: Systemic Fibrinolysis in Symptomatic Intermediate-Risk Pulmonary Embolism: A Real-World Cohort Study
Authors: Eva Cervilla-Muñoz, Pablo Demelo-Rodríguez, Rubén Alonso-Beato, Miriam Juárez-Fernández, Iago Sousa-Casasnovas, Lucía Ordieres-Ortega, Marina López-Rubio, Luis-Antonio Alvarez-Sala Walther, Francisco Galeano-Valle
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care